{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["F. solani", "apoptosis", "cell cycle arrest", "mitochondria membrane potential loss", "sub-acute toxicity", "taxol"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "33117679", "DateRevised": {"Year": "2020", "Month": "10", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "06"}], "Language": ["eng"], "ELocationID": ["538865", "10.3389/fonc.2020.538865"], "Journal": {"ISSN": "2234-943X", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in oncology", "ISOAbbreviation": "Front Oncol"}, "ArticleTitle": "Sub-acute Toxicity Assessment of Taxol Isolated From <i>Fusarium Solani</i>, an Endophytic Fungus of <i>Taxus Brevifolia</i>, in Wistar Rats and Analyzing Its Cytotoxicity and Apoptotic Potential in Lung Cancer Cells.", "Pagination": {"StartPage": "538865", "MedlinePgn": "538865"}, "Abstract": {"AbstractText": ["The limited availability of taxol from plant sources has prompted the scientific world to look for an alternative, as in the chemical synthesis of tissue cultures of the <i>Taxus</i> species, to meet the increasing demand for the drug. However, these alternative means are expensive or result in low yield. Previously, we have reported that <i>Fusarium solani</i> isolated from <i>Taxus celebica</i> produced taxol and its precursor baccatin III in liquid-grown cultures, and it exhibited promising anticancerous effects in certain cancer cell lines. In the present study, we examined the sub-acute toxicity of fungal taxol (FS) in Wistar rats according to the Organization for Economic Co-operation and Development (OECD) guidelines. The sub-acute oral administration of FS up to 500 mg/kg for a period of 28 days appears to be safe in rats and did not cause severe treatment-related toxicity or treatment-related death. The observed changes in body weight, histopathology, hematological and biochemical parameters, and organ weight were not significant compared to those in the control group of animals. The results suggest that FS is relatively safe when administered orally in rats. The antiproliferative and apoptosis-inducing activities were studied in A549 (human lung cancer) cell line. FS arrested the cells at S and G2/M phases, leading to apoptosis. The characteristic molecular signatures of apoptosis, such as externalized phosphatidyl serine, DNA fragmentation, and nuclear and chromatin condensation, were observed upon FS treatment. FS triggered the generation of reactive oxygen species in A549 cells and elicited cell death by both extrinsic as well as the mitochondria-mediated intrinsic pathway of apoptosis. These results indicate that endophytic fungi isolated from medicinal plants may serve as potential sources of anticancerous compounds with little side effects."], "CopyrightInformation": "Copyright \u00a9 2020 Kuriakose, Arathi, Divya Lakshmanan, Jiby, Gudde and Jayabhaskaran."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Indian Institute of Science, Bangalore, India."}], "LastName": "Kuriakose", "ForeName": "Gini C", "Initials": "GC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Indian Institute of Science, Bangalore, India."}], "LastName": "Arathi", "ForeName": "B P", "Initials": "BP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Indian Institute of Science, Bangalore, India."}], "LastName": "Divya Lakshmanan", "ForeName": "Mangalath", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Indian Institute of Science, Bangalore, India."}], "LastName": "Jiby", "ForeName": "M V", "Initials": "MV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Central Animal Facility, Indian Institute of Science, Bangalore, India."}], "LastName": "Gudde", "ForeName": "Ramachandra Subbaraya", "Initials": "RS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Indian Institute of Science, Bangalore, India."}], "LastName": "Jayabhaskaran", "ForeName": "C", "Initials": "C"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Oncol", "NlmUniqueID": "101568867", "ISSNLinking": "2234-943X"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Henley D, Isbill M, Fernando R, Foster JS, Wimalasena J. Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity. Cancer Chemother Pharmacol. (2007) 59:235\u201349. 10.1007/s00280-006-0262-1", "ArticleIdList": ["10.1007/s00280-006-0262-1", "16972069"]}, {"Citation": "Jones WB, Schneider J, Shapiro F, Lewis JL, Jr. Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases. Gynecol Oncol. (1996) 61:126\u201330. 10.1006/gyno.1996.0110", "ArticleIdList": ["10.1006/gyno.1996.0110", "8626100"]}, {"Citation": "Park SJ, Wu CH, Gordon JD, Zhong X, Emami A, Safa AR. Taxol induces caspase10-dependent apoptosis. J Biol Chem. (2004) 279:51057\u201367. 10.1074/jbc.M406543200", "ArticleIdList": ["10.1074/jbc.M406543200", "15452117"]}, {"Citation": "Tan M, Yu D. Molecular mechanisms of erbB2-mediated breast cancer chemo resistance. Adv Exp Med Biol. (2007) 608:119\u201329. 10.1007/978-0-387-74039-3_9", "ArticleIdList": ["10.1007/978-0-387-74039-3_9", "17993237"]}, {"Citation": "Woo HL, Swenerton KD, Hoskins PJ. Taxol is active in platinum-resistant endometrial adenocarcinoma. Am J Clin Oncol. (1996) 19:290\u20131. 10.1097/00000421-199606000-00016", "ArticleIdList": ["10.1097/00000421-199606000-00016", "8638543"]}, {"Citation": "Zhou HB, Zhu JR. Paclitaxel induces apoptosis in human gastric carcinoma cells. World J Gastroenterol. (2003) 9:442\u20135. 10.3748/wjg.v9.i3.442", "ArticleIdList": ["10.3748/wjg.v9.i3.442", "PMC4621557", "12632493"]}, {"Citation": "Heinig U, Jennewein S. Taxol: a complex diterpenoid natural product with an evolutionarily obscure origin. Afr J Biotechnol. (2009) 8:1370\u201385. 10.5897/AJB2009.000-9217", "ArticleIdList": ["10.5897/AJB2009.000-9217"]}, {"Citation": "Deng BW, Liu KH, Chen WQ, Ding XW, Xie XC. Fusarium solani, Tax-3, a new endophytic taxol-producing fungus from Taxuschinensis. World J Microbiol Biotechnol. (2009) 25:139\u201343. 10.1007/s11274-008-9876-2", "ArticleIdList": ["10.1007/s11274-008-9876-2"]}, {"Citation": "Gangadevi V, Muthumary J. Taxol, an anticancer drug produced by an endophytic fungus Bartalinia robillardoides Tassi, isolated from a medicinal plant, Aegle marmelos Correa ex Roxb. World J Microbiol Biotechnol. (2008) 24:717\u2013724. 10.1007/s11274-007-9530-4", "ArticleIdList": ["10.1007/s11274-007-9530-4"]}, {"Citation": "Gokul Raj K, Manikandan R, Arulvasu C, Pandi M. Anti-proliferative effect of fungal taxol extracted from Cladosporiumoxysporum against human pathogenic bacteria and human colon cancer cell line HCT 15. Spectrochimica Acta A. (2015) 138:667\u201374. 10.1016/j.saa.2014.11.036", "ArticleIdList": ["10.1016/j.saa.2014.11.036", "25544183"]}, {"Citation": "Huang Y, Wang J, Li G, Zheng Z, Su W. Antitumor and antifungal activities in endophytic fungi isolated from pharmaceutical plants Taxusmairei, Cephalataxusfortunei and Torreyagrandis. FEMS Immunol Med Microbiol. (2001) 31:163\u20137. 10.1111/j.1574-695X.2001.tb00513.x", "ArticleIdList": ["10.1111/j.1574-695X.2001.tb00513.x", "11549424"]}, {"Citation": "Zhou X, Zhu H, Tang K. A review: recent advances and future prospects of Taxol- producing endophytic fungi. Appl Micobial Biotechnol. (2010) 86:1707\u201317. 10.1007/s00253-010-2546-y", "ArticleIdList": ["10.1007/s00253-010-2546-y", "20358192"]}, {"Citation": "Chakravarthi BV, Sujay R, Kuriakose GC, Karande AA, Jayabaskaran C. Inhibition of cancer cell proliferation and apoptosis-inducing activity of fungal taxol and its precursor baccatin III purified from endophytic Fusarium solani. Cancer Cell Int. (2013) 13:105 10.1186/1475-2867-13-105", "ArticleIdList": ["10.1186/1475-2867-13-105", "PMC4016216", "24152585"]}, {"Citation": "Steed H, Sawyer MB. Pharmacology, pharmacokinetics and pharmacogenomics of paclitaxel. Pharmacogenomics. (2007) 8:803\u201315. 10.2217/14622416.8.7.803", "ArticleIdList": ["10.2217/14622416.8.7.803", "17638515"]}, {"Citation": "Trudeau ME. First-line treatment of metastatic breast cancer. Anticancer Drugs. (1996) 2:9\u201312. 10.1097/00001813-199608002-00003", "ArticleIdList": ["10.1097/00001813-199608002-00003", "8862703"]}, {"Citation": "Horwitz SB. Mechanism of action of Taxol. Trends Pharmacol Sci. (1992) 13:134\u20136. 10.1016/0165-6147(92)90048-B", "ArticleIdList": ["10.1016/0165-6147(92)90048-B", "1350385"]}, {"Citation": "Dai M-S, Chao T-C, Chiu C-F, Lu Y-S, Shiah H-S, Wu Y-Y, et al. Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients. J Clin Oncol. (2019) 37(suppl 15):1084 10.1200/JCO.2019.37.15_suppl.1084", "ArticleIdList": ["10.1200/JCO.2019.37.15_suppl.1084"]}, {"Citation": "Jackson CGCA, Deva S, Bayston K, McLaren B, Barlow P, Hung NA, et al. An international randomized cross-over bioequivalence study of oral paclitaxel + HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumors. Ann Oncol. (2019) 39(suppl 5):v159\u2013v93. 10.1093/annonc/mdz244.039", "ArticleIdList": ["10.1093/annonc/mdz244.039"]}, {"Citation": "Umanzor G, Rugo HS, Barrios FJ, Vasallo RH, Chivalan MA, Bejarano S, et al. Oral paclitaxel with encequidar (OPE): the first orally administered paclitaxel shown to be superior to IV paclitaxel on confirmed response and survival with less neuropathy: a phase III clinical study in metastatic breast cancer. In: Presented at: 2019 San Antonia Breast Cancer Symposium. San Antonio, TX: (2019)."}, {"Citation": "Ekanayake CP, Thammitiyagodage MG, Padumadasa S, Seneviratne B, Padumadasa C, Abeysekera AM. Acute and subacute toxicity studies of the ethyl acetate soluble proanthocyanidins of the immature inflorescence of Cocos nucifera L. in female Wistar rats. Biomed Res Int. (2019) 2019:8428304. 10.1155/2019/8428304", "ArticleIdList": ["10.1155/2019/8428304", "PMC6926421", "31886260"]}, {"Citation": "Li Y, Zhang X, Liang C, Hu J, Yu Z. Safety evaluation of mulberry leaf extract: acute, subacute toxicity and genotoxicity studies. Regul Toxicol Pharmacol. (2018) 95:220\u20136. 10.1016/j.yrtph.2018.03.007", "ArticleIdList": ["10.1016/j.yrtph.2018.03.007", "29530616"]}, {"Citation": "Vijayaraghavan R, Singh M, Rao PV, Bhattacharya R, Kumar P, Sugendran K, et al. . Subacute (90 Days) oral toxicity studies of kombucha tea. Biomed Environ Sci. (2000) 13:293\u20139.", "ArticleIdList": ["11351863"]}, {"Citation": "Yuet Ping K, Darah I, Chen Y, Sreeramanan S, Sasidharan S. Acute and subchronic toxicity study of Euphorbia hirta L. methanol extract in rats. Biomed Res Int. (2013) 182064. 10.1155/2013/182064", "ArticleIdList": ["10.1155/2013/182064", "PMC3872372", "24386634"]}, {"Citation": "Rege BD, Kao JPY, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci. (2002) 16:237\u201346. 10.1016/S0928-0987(02)00055-6", "ArticleIdList": ["10.1016/S0928-0987(02)00055-6", "12208453"]}, {"Citation": "Chakravarthi BV, Das P, Surendranath K, Karande AA, Jayabaskaran C. Production of paclitaxel by Fusarium solani isolated from Taxuscelebica. J Biosci. (2008) 33:259\u201367. 10.1007/s12038-008-0043-6", "ArticleIdList": ["10.1007/s12038-008-0043-6", "18535360"]}, {"Citation": "OECD Guidelines for Testing of Chemical. Acute Oral Toxicity - Up-and-Down-Procedure. OECD: Paris: (2008)."}, {"Citation": "OECD Guidelines for Testing of Chemical. Repeated Dose 28-Day Oral Toxicity Study in Rodents. OECD: Paris: (2008)."}, {"Citation": "Kuriakose GC, Lakshmanan MD, Bp A, Rs HK, Th AK, Ananthaswamy KC, Extract of Penicillium sclerotiorum an endophytic fungus isolated from Cassia fistula L . induces cell cycle arrest leading to apoptosis through mitochondrial membrane depolarization in human cervical cancer cells. Biomed Pharmacother. (2018) 105:1062\u201371. 10.1016/j.biopha.2018.06.094", "ArticleIdList": ["10.1016/j.biopha.2018.06.094", "30021342"]}, {"Citation": "Hingorani R, Deng J, Elia J, McIntyre C, Mitta D. Detection of Apoptosis Using the BD Annexin V FITC Assay on the BD FACSVerse\u2122 System. Application Note, BD Bioscience; (2011)."}, {"Citation": "Vermeulen K, Van Bockstaele DR, Berneman ZN. Apoptosis mechanisms and relevance in cancer. Ann Hematol. (2005) 84:627\u201339. 10.1007/s00277-005-1065-x", "ArticleIdList": ["10.1007/s00277-005-1065-x", "16041532"]}, {"Citation": "Ivanova D, Zhelev Z, Aoki I, Bakalova R, Higashi T. Overproduction of reactive oxygen species - obligatory or not for induction of apoptosis by anticancer drugs. Chin J Cancer Res. (2016) 28:383\u201396. 10.21147/j.issn.1000-9604.2016.04.01", "ArticleIdList": ["10.21147/j.issn.1000-9604.2016.04.01", "PMC5018533", "27647966"]}, {"Citation": "Green DR, Llambi F. Cell death signaling. Cold Spring Harb Perspect Biol. (2015) 7:a006080 10.1101/cshperspect.a006080", "ArticleIdList": ["10.1101/cshperspect.a006080", "PMC4665079", "26626938"]}, {"Citation": "Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol. Ther. (2005) 4:139\u201363. 10.4161/cbt.4.2.1508", "ArticleIdList": ["10.4161/cbt.4.2.1508", "15725726"]}, {"Citation": "Li D, Ueta E, Kimura T, Yamamoto T, Osaki T. Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci. (2004) 95:644\u201350. 10.1111/j.1349-7006.2004.tb03323.x", "ArticleIdList": ["10.1111/j.1349-7006.2004.tb03323.x", "15298726"]}, {"Citation": "Chen J. The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med. (2016) 6:a026104. 10.1101/cshperspect.a026104", "ArticleIdList": ["10.1101/cshperspect.a026104", "PMC4772082", "26931810"]}, {"Citation": "el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. . WAF1, a potential mediator of p53 tumor suppression. Cell. (1993) 75:817\u201325. 10.1016/0092-8674(93)90500-P", "ArticleIdList": ["10.1016/0092-8674(93)90500-P", "8242752"]}, {"Citation": "Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. (1993) 75:805\u201316. 10.1016/0092-8674(93)90499-G", "ArticleIdList": ["10.1016/0092-8674(93)90499-G", "8242751"]}, {"Citation": "Westphal D, Dewson G, Czabotar PE, Kluck RM. Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta. (2011) 1813:521\u201331. 10.1016/j.bbamcr.2010.12.019", "ArticleIdList": ["10.1016/j.bbamcr.2010.12.019", "21195116"]}, {"Citation": "Chinnaiyan AM. The apoptosome: heart and soul of the cell death machine. Neoplasia. (1999) 1:5\u201315. 10.1038/sj.neo.7900003", "ArticleIdList": ["10.1038/sj.neo.7900003", "PMC1716059", "10935465"]}]}], "History": [{"Year": "2020", "Month": "2", "Day": "28"}, {"Year": "2020", "Month": "8", "Day": "14"}, {"Year": "2020", "Month": "10", "Day": "29", "Hour": "5", "Minute": "53"}, {"Year": "2020", "Month": "10", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "30", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["33117679", "PMC7574678", "10.3389/fonc.2020.538865"]}}]}